India Life Science & Analytical Instruments market size was valued at USD 0.27 Billion in 2023. The India Life Science & Analytical Instruments market industry is projected to grow from USD 0.30 Billion in 2024 to USD 0.73 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.40% during the forecast period (2024 - 2032).
Rising demand for analytical instruments in different sectors is one of the major factors driving the growth of the India life science and analytical instruments market. Likewise, increasing pharmaceutical R&D investment and rising adoption of technologically based life sciences and analytical instruments are further fueling the growth of the India market during the review period.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The increasing demand for analytical instruments in sectors such as pharmaceutical and biotechnology companies, hospitals, and diagnostic laboratories. In India, pharmaceutical and biotechnology companies are adopting appropriate laboratory instruments in order to support the drug discovery process. The increasing demand for small-molecule drugs, innovative biologics, regenerative pharmaceuticals, and biopharmaceuticals further increases the requirement for analytical instrumentation in the pharmaceutical and biotechnology sectors. Moreover, there are several trends associated with the pharmaceutical and biopharmaceutical sectors that support market growth. The trends include rapid approvals of novel therapeutics, rising investment in cell and gene therapy, investments by biotechnological companies, contract research organisations (CROs), and contract manufacturing organisations (CMOs). Moreover, the increasing number of infectious diseases in India further demands the use of analytical instruments for research purposes in research and academic institutes. The research on emerging and reemerging infectious diseases in Europe includes human immunodeficiency virus (HIV), chikungunya, influenza, hepatitis B, hepatitis C, and dengue. In November 2023, the Department of Biology (India) announced that the Infectious Disease Biology Program supports R&D projects that assist in developing treatments for infectious diseases. Furthermore, infectious diseases, including lower respiratory infections, neonatal disorders, and tuberculosis, are among the top 10 causes of the total number of deaths in the country.
The India Life Science & Analytical Instruments market segmentation, based on instrument type, includes sterilizers, bioreactors, washers, isolators, aseptic transfer equipment, and others. The others segment held the largest market share in 2022, and bioreactors is the fastest-growing segment during the forecast period. The others segment includes sterile filters, sterile tubing and hoses and aseptic connectors. The bioreactors segment is further divided into production scale and single use. Production scale bioreactors are large scale vessels used in the cultivation of microorganisms or cells to produce various biological products in the field of life sciences. Furthermore, the high productivity, process control and monitoring, and flexibility in production are some driving factors for the segment. Moreover, the single-use bioreactors are designed for one-time use in the cultivation of cells or microorganisms.
The India Life Science & Analytical Instruments market segmentation, based on application, includes clinical and diagnostics, research, and others. The research segment held the largest market share in 2022, and clinical and diagnostics is the fastest-growing segment during the forecast period. Increased public-private financing in genomic research, as well as the continued trend of laboratory automation and robotics, all contribute to a substantial proportion of the research applications market. Furthermore, the quickly expanding healthcare infrastructure, equipment, advanced technology, and skilled staff to perform complex tests all contribute to market growth.
Figure 2: India Life Science & Analytical Instruments Market, by Application, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The India Life Science & Analytical Instruments market segmentation, based on end user, includes pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, and others. The pharmaceutical and biotechnology companies segment held the largest market share in 2022, and hospitals and diagnostic laboratories segment is the fastest-growing segment during the forecast period i.e., 2022-2032. The pharmaceutical & biotechnology industry is contributing significantly to the market's growth in India. The bioprocessing sector is emerging as a substantial player in the market under examination, with an increasing emphasis on pharmaceutical quality manufacturing. To widen their reach and cut operational expenses, the corporations have adopted a strategy of seeking regulatory approval from government bodies for their products and negotiating contracts and agreements.
India Life Science & Analytical Instruments Key Market Players & Competitive Insights
The India Life Science & Analytical Instruments market is distinguished by the presence of numerous local players catering to products that are evolving at a rapid pace. Furthermore, the Rising demand for analytical instruments in different sectors and increasing investments in pharmaceutical R&D is further driving the growth of India Life Science & Analytical Instruments market during the forecast period. The major players have adopted a strategy of obtaining regulatory approval from government agencies for their products and signing contracts and agreements to broaden their reach and reduce operational costs. For instance, in January 2019, Sartorius AG (Germany) launched the BIOSTAT RM TX single-use bioreactor, a novel wave mixed system specifically designed for the closed, automated expansion of dependable, high-quality cell products like ex vivo cellular immunotherapies. The product is available across India, and US, Europe, and Asian countries.
Shimadzu Corporation (Shimadzu) is a manufacturer and distributor of precision instruments. The company offers spectrometers, inspection systems, carbon analyzers, hydraulic equipment, onboard flight management systems, flight control systems, and cockpit display systems in addition to high-performance liquid chromatography (HPLC), liquid transmission equipment, intelligence technologies, and X-ray systems. The company serves a variety of industries, such as healthcare (hospitals and clinics), pharmaceuticals, chemicals, aerospace, food and beverage, education, construction, and other industries. It has 13 global manufacturing plants, 5 of which are in Japan and 8 elsewhere. Additionally, it markets goods globally via a network of wholesalers. Furthermore, it has operations in North America, Europe, Asia, South & Central America, Middle East & Africa, and Oceana.
Key Companies in the India Life Science & Analytical Instruments market includes.
India Life Science & Analytical Instruments Industry Developments
| Report Attribute/Metric | Details |
| Market Size 2023 | USD 0.27 Billion |
| Market Size 2024 | USD 0.30 Billion |
| Market Size 2032 | USD 0.73 Billion |
| Compound Annual Growth Rate (CAGR) | 10.40% (2024-2032) |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2019 to 2021 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Instrument Type, Application, and end user |
| Key Companies Profiled | Getinge (Sweden), Shimadzu Corporation (Japan), Sartorius AG (Germany), Pharmalab India Private Limited (India), Thermo Fisher Scientific Inc (US), Agilent Technologies Inc (US), QIAGEN (Germany), PerkinElmer, Inc. (US), Bio-Rad Laboratories, Inc. (US), and STERIS plc (Ireland) |
| Key Market Opportunities | ·      Growing geriatric population ·      Increasing population |
| Key Market Drivers | ·      Rising demand for analytical instruments in different sectors ·      Increasing pharmaceutical R&D investment ·      Rising adoption of technologically based life sciences and analytical instruments |
Frequently Asked Questions (FAQ) :
The India life science & analytical instruments market is anticipated to reach 0.73 billion at a CAGR of 10.40% during the forecast period of 2024-2032.
The India life science & analytical instruments market is expected to grow at a 10.40% CAGR during the forecast period from 2024 to 2032.
The key players include Getinge (Sweden), Thermo Fisher Scientific Inc (US), Agilent Technologies Inc (US), PerkinElmer, Inc. (US), and Sartorius AG (Germany).
The others segment led the India life science & analytical instruments market.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
